Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17:530–8. https://doi.org/10.1016/S1474-4422(18)30107-8.
2. Tomson T, Battino D, Perucca E. Teratogenicity of antiepileptic drugs. Curr Opin Neurol. 2019;32:246–52. https://doi.org/10.1097/WCO.0000000000000659.
3. Güveli BT, Rosti RÖ, Güzeltaş A, Tuna EB, Atakl D, Sencer S, et al. Teratogenicity of antiepileptic drugs. Clin Psychopharmacol Neurosci. 2017;15:19–27. https://doi.org/10.9758/cpn.2017.15.1.19.
4. European Medicines Agency. Assessment report. Procedure under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data. Substances related to valproate. Procedure number: EMEA/H/A-31/1387. 2014.
5. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. Member State representatives agree new restrictions and pregnancy prevention programme. . EMA/375438/2018 2018. https://www.ema.europa.eu/en/documents/referral/valproate-article-31-referral-new-measures-avoid-valproate-exposure-pregnancy-endorsed_en-0.pdf (accessed Sep 6, 2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献